Related Experiment Videos
Microarray-based method for detecting methylation changes of p16(Ink4a) gene 5'-CpG islands in gastric carcinomas
Peng Hou1, Jia-Yao Shen, Mei-Ju Ji
1Chien-Shiung Wu Laboratory, Department of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, Jiangsu Province, China.
World Journal of Gastroenterology
|November 10, 2004
Summary
A new microarray assay effectively detects DNA methylation changes in cancer, offering a high-throughput method for analyzing tumor suppressor genes like p16 in gastric carcinomas.
Area of Science:
- Cancer epigenetics
- Molecular diagnostics
- Genomic analysis
Background:
- Aberrant DNA methylation is an early and common event in cancer.
- CpG site methylation in tumor suppressor genes is linked to carcinogenesis.
- High-throughput DNA methylation analysis is needed for large-scale studies.
Purpose of the Study:
- To develop and describe a microarray-based method for detecting DNA methylation changes in cancer.
- To assess the utility of this method for analyzing CpG islands of the p16 gene in gastric cancer.
Main Methods:
- Bisulfite modification of DNA followed by PCR amplification.
- Design of oligonucleotide probes for a DNA microarray targeting p16 gene CpG islands.
- Validation of microarray results using methylation-specific PCR (MSP).
Main Results:
- The microarray assay successfully identified p16 gene methylation in 18 gastric tumor samples.
- The method demonstrated potential for higher detection frequency of p16 methylation compared to MSP.
- Microarray analysis enabled mapping of methylation changes across multiple CpG loci.
Conclusions:
- Microarray assay is a valuable tool for profiling cancer epigenetics.
- This method facilitates the mapping of DNA methylation alterations in cancer.
- The developed assay aids in generating comprehensive epigenetic profiles for cancer research.